Subgroup Analysis of Patients With and Without p53-Ab in Serum
death
In the p53-Ab (+) group, relapse or death occurred in 17 of 86 patients (19.8%) in the vitamin D group and 19 of 56 patients (33.9%) in the placebo group; 5-year RFS was 26 patients (77.2%) in the vitamin D group and 10 patients (60.0%) in the placebo group, indicating no significant difference (HR, 0.57; 95% CI, 0.30-1.10) (